Singapore Built Biomedical Research With Stem Cells U.S. Banned
This article was originally published in PharmAsia News
Executive Summary
Singapore's laws that make it easier to conduct research using embryonic stem cells are responsible for the nation building a biomedical research sector, a U.S. scientist said